NCT03961178

Brief Summary

This study is to investigate the oncologic and obstetric outcomes in patients with conization for uterine cervical lesions from January 1, 2000 to January 1, 2019 in Peking Union Medical College Hospital. The primary objectives consist of following:

  1. 1.The cumulative incidences of precancerous lesions and cancers of lower genital tract in patients who accepted conization for high grade intraepithelial neoplasia (HSIL), carcinoma in situ and stage IA1 cancer (FIGO 2009)
  2. 2.The cumulative pregnancy rates in patients sparing the fertility
  3. 3.The effects of surgical protocols (modified Sturmdorf method and "8" figure suture) and energy equipment (cold knife and monopolar electrical cautery) on the oncologic and obstetric outcomes, and on the histological components.
  4. 4.A full description of histological components of the conization specimens
  5. 5.The cytological and virus outcomes after conization, based on the thin prep liquid-based cytology test (TCT) and high-risk human papillomavirus (HPV) testing

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 23, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

June 3, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2021

Completed
Last Updated

June 20, 2019

Status Verified

June 1, 2019

Enrollment Period

2 years

First QC Date

May 22, 2019

Last Update Submit

June 19, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • The cumulative incidences of precancerous lesions or cancers

    The cumulative incidences of precancerous lesions and cancers of lower genital track in patients who accepted conization for high grade intraepithelial neoplasia (HSIL), carcinoma in situ and stage IA1 cancer (FIGO 2009)

    Five years

  • The cumulative pregnancy rates

    The cumulative pregnancy rates in patients sparing the fertility

    Five years

Secondary Outcomes (4)

  • The cytological results after conization

    Five years

  • The virus outcomes after conization

    Five years

  • The cumulative pregnancy loss rates

    Five years

  • The cumulative live birth rates

    Five years

Interventions

High-risk HPVDIAGNOSTIC_TEST

High-risk HPV testing for the cytology of lower genital tract

TCTDIAGNOSTIC_TEST

Thin prep liquid-based cytology test for the cytology of lower genital tract

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients accepting conization in the study center who were aged 18 years or older.

You may qualify if:

  • Accepting conization in the study center
  • Aged 18 years or older

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lei Li

Beijing, Beijing Municipality, 100730, China

RECRUITING

MeSH Terms

Conditions

Uterine Cervical NeoplasmsPapillomavirus Infections

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lei Li, M.D.

    Peking Union Medical College Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ming Wu, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 22, 2019

First Posted

May 23, 2019

Study Start

June 3, 2019

Primary Completion

May 22, 2021

Study Completion

May 22, 2021

Last Updated

June 20, 2019

Record last verified: 2019-06

Locations